KRINTAFEL (TAFENOQUINE) 150MG TABLETS

GlaxoSmithKline UK

Revision date : 2022-04-26

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS07 GHS09
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

N/A

EC/CAS

9004-34-6

Name of the chemical

cellulose

Concentration

N/A

EC/CAS

9004-65-3

Name of the chemical

methylhydroxypropylcellulose

Concentration

N/A

General Information

Revision date

2022-04-26

Product name

KRINTAFEL (TAFENOQUINE) 150MG TABLETS

Product Synonyms

TAFENOQUINE FILM-COATED TABLET * TAFENOQUINE [150MG] FILM-COATED TABLET *

1.2.2. Uses advised against

No other uses are advised Details of principal suppliers

Icons in SDS

Company Information

company name

GlaxoSmithKline UK

e-mail address of the competent person responsible for the Safety Data Sheet

msds@gsk.com

GHS Information

Signal word

Danger

Section 2

Physical hazards

Not classified.

Health hazards

Acute toxicity (oral) Category 4 Specific target organ toxicity - repeated Category 1 exposure

Environmental hazards

Hazardous to the aquatic environment - acute Category 1 Hazardous to the aquatic environment - Category 1 chronic hazard

Signal word

Danger

Hazard statements

Harmful if swallowed. Causes damage to organs through prolonged or repeated exposure. Very toxic to aquatic life. Very toxic to aquatic life with long lasting effects.

Prevention

Do not breathe dust. Wash thoroughly after handling. Do not eat, drink, or smoke when using this product. Avoid release to the environment.

Response

IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell. Rinse mouth. Get medical advice/attention if you feel unwell. Collect spillage.

Storage

Not available.

Disposal

Dispose of contents/container in accordance with local/regional/national/international regulations.

Other hazards which do not result in classification

Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.

Additional information

57.8 % of the mixture consists of component(s) of unknown acute oral toxicity. 81.4125 % of the mixture consists of component(s) of unknown acute dermal toxicity. 81.4125 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 61.1125 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 61.1125 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment. Section 3: Composition and information of the ingredients of the hazardous chemical

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.